More than 500 kinds of Chinese medicine tablets are included in medical insurance, and the market is expected to further expand

【Pharmaceutical Network Industry News】Chinese medicine tablets are one of the three pillars of
China's traditional Chinese medicine industry.
In recent years, under the national basic medicine, national medical insurance and other policies, Chinese medicine tablets have developed rapidly
.
The industry said that with more and more Chinese medicine tablets and Chinese medicine formula granules included in medical insurance, the space for patients to use traditional Chinese medicine has increased, and the market is expected to further expand
.
The author learned that recently, the Hunan Provincial Medical Insurance Bureau issued a notice
on the implementation of traditional Chinese medicine tablets newly included in the "Catalogue of Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drugs" in Hunan Province in 2022.
According to the notice, 551 kinds of Chinese medicine tablets that meet the conditions have been officially added to the scope of medical insurance payment, and have been officially implemented in Hunan Province since October 1, with a validity period of 3 years
.
The "Notice" pointed out that a total of 551 kinds of new Chinese medicine tablets were added this time, which were divided into two parts
: "traditional Chinese medicine tablets" and "non-traditional Chinese medicine tablets".
Among them, there are 114 kinds of traditional Chinese medicine tablets and 437 kinds of non-traditional Chinese medicine tablets (including 299 kinds of Chinese medicine formula granules and 138 kinds of Chinese medicine ultra-micro tablets).
The traditional Chinese medicine tablets corresponding to the varieties of non-traditional Chinese medicine tablets have been included in the national medical insurance catalogue of traditional Chinese medicine tablets or the new list of traditional Chinese medicine tablets in Hunan Province, and only those that meet the relevant standards of the state and Hunan Province can be included in the medical insurance payment
.
In terms of treatment payment standards, the notice points out: (1) The newly added Chinese medicine tablets implement the management of the B catalogue, pay according to the name of the catalog, and do not distinguish between manufacturers
.
The personal out-of-pocket payment ratio of the "traditional Chinese medicine tablets" varieties is set to 0, and the "non-traditional Chinese medicine drinking tablets" varieties are implemented
according to the published personal out-of-pocket payment ratio.
Work-related injury insurance does not set a self-payment ratio and is paid
in accordance with the provisions of the work-related injury insurance policy.
(2) The "Remarks" column of the newly added Chinese medicine tablets is limited to the scope of payment for medical insurance, and if "□" is marked, it will not be paid when used separately, and the prescription composed of all these tablets will not be paid
.
(3) If the 406 kinds of Chinese medicine ultra-micro tablets that were originally included in the scope of payment of medical work-related injury maternity insurance in Hunan Province have been included in the scope of the new Chinese medicine tablets, they shall be implemented in accordance with the provisions of this Notice, and if they are not included in the scope of the new Chinese medicine tablets, the payment date will be until December 31, 2022, and the payment
will not be made after expiration.
It is understood that due to the good mass base, Chinese medicine tablets are widely used, and at the same time, under the impetus of policies such as not being restricted by the proportion of drugs and allowing additions, Chinese medicine tablets have shown vigorous development potential
.
In recent years, the Chinese medicine tablet market has developed rapidly, and data show that the processing market size of Chinese medicine tablets will reach 178.
2 billion yuan in 2020.

In addition, data show that the total profit of traditional Chinese medicine tablets in the first half of this year reached 7.
88 billion yuan, an increase of 20.
3%
year-on-year.
The total profit of the Chinese medicine tablet industry in the first half of this year also accounted for 2.
97% of the total profit of the national pharmaceutical industry from 1.
93% in the same period of 2021
.
In order to better promote the development of traditional Chinese medicine tablets, China continues to give encouragement
in policy.
Among them, from the perspective of medical insurance policy, among the 2860 drugs included in the national medical insurance catalogue in 2021, there are 93 ethnic medicines and 892 traditional Chinese medicine tablets
.
According to relevant statistics, the total number of traditional Chinese medicine tablets manufacturers in China in 2021 has reached more than 2,000, of which 850 enterprises have oral drinking tablets qualifications
.
From the national to the local, the Chinese medicine tablets are included in medical insurance, and some people in the industry believe that this is the state encouraging and supporting the development of the traditional Chinese medicine industry from the policy point of view, and the amount of traditional Chinese medicine in the hospital is expected to be further improved
.
Disclaimer: Under no circumstances does the information herein or the opinions expressed in this article constitute investment advice
to any person.